# US 2015/0147457 A1 · Isotopically modified compounds and their use as food supplements

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0147457 A1
- Document ID: US20150147457A1
- Status: Published application
- Kind: A1
- Application number: 14/551,450
- Filed: 2014-11-24
- Published: 2015-05-28
- Earliest claimed: 2006-03-08
- Assignees: Retrotope, Inc.
- Applicants: Retrotope, Inc.
- Inventors: Mikhail Sergeevich Shchepinov
- Web page: https://patentgrep.com/patent/US20150147457A1

## CPC

- A23L 33/12: Fatty acids or derivatives thereof
- A23D 9/00: Other edible oils or fats, e.g. shortenings or cooking oils (preservation of other edible oils A23B20/30)
- A23D 9/007: characterised by ingredients other than fatty acid triglycerides
- A23K 10/12: by fermentation of natural products, e.g. of vegetable material, animal waste material or biomass
- A23K 50/80: for aquatic animals, e.g. fish, crustaceans or molluscs
- A23L 33/10: using additives (addition of substantially indigestible substances A23L33/21)
- A23L 33/105: Plant extracts, their artificial duplicates or their derivatives
- A23L 33/13: Nucleic acids or derivatives thereof (A23L33/145 takes precedence)
- A23L 33/135: Bacteria or derivatives thereof, e.g. probiotics
- A23L 33/175: Amino acids
- A23L 33/18: Peptides; Protein hydrolysates
- A23L 33/20: Reducing nutritive value; Dietetic products with reduced nutritive value
- A61K 9/0019: {Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner (non-active ingredients are additionally classified in A61K47/00)}
- A61K 31/201: having one or two double bonds, e.g. oleic, linoleic acids
- A61P 39/06: Free radical scavengers or antioxidants
- C07C 57/03: Monocarboxylic acids
- C07C 229/26: having more than one amino group bound to the carbon skeleton, e.g. lysine
- C07C 255/30: containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the same unsaturated acyclic carbon skeleton
- C07C 279/14: being further substituted by carboxyl groups
- C07H 19/16: Purine radicals
- A23V 2002/00: Food compositions, function of food ingredients or processes for food or foodstuffs
- C07B 2200/05: Isotopically modified compounds, e.g. labelled
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- A23D: EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS (preservation thereof A23B20/00; production, refinement or preservation of animal or vegetable fats or oils C11B, C11C)
- A23K: FODDER
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07H: SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS (derivatives of aldonic or saccharic acids C07C, C07D; aldonic acids, saccharic acids C07C59/105, C07C59/285; cyanohydrins C07C255/16; glycals C07D; compounds of unknown constitution C07G; polysaccharides, derivatives thereof C08B; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; sugar industry C13)
- A23V: INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- C07B: GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR (preparation of carboxylic acid esters by telomerisation C07C67/47; telomerisation C08F)

## Abstract

A nutrient composition comprises an essential nutrient in which at least one exchangeable H atom is 2H and/or at least one C atom is 13C. The nutrient is thus protected from, inter alia, active oxygen species.

## Claims

### Claim at position 1

1-18. (canceled)

### Claim 19

A foodstuff, comprising an isotopically modified component;
wherein the isotopically modified component is a fatty acid or fat that is isotopically modified at least at one or more bis-allylic positions;
wherein the amount of the isotopically modified component is at least 0.1% of the foodstuff; and
wherein the amount of the isotopically modified component is sufficient to reduce the extent of lipid oxidation in a patient.

### Claim 20 (depends on 19)

The foodstuff of claim 19, wherein amount of the isotopically modified component is sufficient to significantly reduce lipid oxidation mediated by free radicals, reactive oxygen species, reactive nitrogen species, or radiation in the subject.

### Claim 21 (depends on 20)

The foodstuff of claim 20, wherein the amount of the isotopically modified component is sufficient to significantly reduce lipid oxidation mediated by free radicals.

### Claim 22 (depends on 19)

The foodstuff of claim 19, wherein the isotopically modified component resists degradation initiated by enzymes of the P450 pathway.

### Claim 23 (depends on 19)

The foodstuff of claim 19, wherein the isotopically modified component or metabolite thereof is a fatty acid that is an essential food component.

### Claim 24 (depends on 19)

The foodstuff of claim 19, wherein the fatty acid or fat is isotopically modified at least one bis-allylic position.

### Claim 25 (depends on 24)

The foodstuff of claim 24, wherein the fatty acid is 11-D-linoleic acid or 11,11-D2-linoleic acid.

### Claim 26 (depends on 25)

The foodstuff of claim 25, wherein the fatty acid is 11,11-D2-linoleic acid.

### Claim 27 (depends on 19)

The foodstuff of claim 19, further comprising non-isotopically-modified essential nutrients.

### Claim 28 (depends on 27)

The foodstuff of claim 27, wherein the ratio of the fatty acid or fat that is isotopically modified to the same fatty acid or fat that is non-isotopically modified fatty acid is greater than 1:1.

### Claim 29 (depends on 19)

The foodstuff of claim 19, wherein the isotopic modification comprises at least one 13C atom or at least one deuterium atom at the one or more bis-allylic positions, wherein the at least one 13C atom or the at least one deuterium atom are present at a level significantly above the naturally-occurring abundance level of said isotope in said fatty acid.

### Claim 30 (depends on 29)

The foodstuff of claim 29, wherein the isotopically modified fatty acid is 11-D-linoleic acid or 11,11-D2-linoleic acid.

### Claim 31 (depends on 30)

The foodstuff of claim 30, wherein the isotopically modified fatty acid is 11-D-linoleic acid.

### Claim 32 (depends on 19)

The foodstuff of claim 19, wherein the fatty acid is a polyunsaturated substance.

### Claim 33 (depends on 19)

The foodstuff of claim 19, wherein the isotopically modified fatty acid is 11-D-linoleic acid or 11,11-D2-linoleic acid.

### Claim 34 (depends on 33)

The foodstuff of claim 33, wherein the isotopically modified fatty acid is 11-D-linoleic acid.

### Claim 35 (depends on 19)

The foodstuff of claim 19, wherein the fatty acid is a carboxylic acid.

### Claim 36 (depends on 19)

The foodstuff of claim 19, wherein the foodstuff is suitable for human consumption.

### Claim 37 (depends on 19)

The foodstuff of claim 19, wherein the deuterium replaces a hydrogen at an oxidation-sensitive site of the fatty acid or fat or at a site that becomes oxygen sensitive upon enzymatic desaturation or elongation.

### Claim 38 (depends on 19)

The foodstuff of claim 19, further comprising an isotopically modified amino acid or nucleic acid base in an amount of at least 0.1% of the foodstuff.
